首页   按字顺浏览 期刊浏览 卷期浏览 Fluphenazine Decanoate and Fluphenazine Enanthate in the Out-Patient Management of Chro...
Fluphenazine Decanoate and Fluphenazine Enanthate in the Out-Patient Management of Chronic Schizophrenia

 

作者: D.J. MacCrimmon,   B. Saxena,   P. Foley,   P. Grof,  

 

期刊: Neuropsychobiology  （Karger Available online 1978）
卷期: Volume 4, issue 6  

页码: 360-365

 

ISSN:0302-282X

 

年代: 1978

 

DOI:10.1159/000117652

 

出版商: S. Karger AG

 

关键词: Fluphenazine decanoate;Fluphenazine enanthate;Out-patient;Chronic schizophrenia;Long-acting intramuscular neuroleptics

 

数据来源: Karger

 

摘要:

39 chronic schizophrenic out-patients were given either fluphenazine decanoate or enanthate for a 1-year double-blind trial. Doses of 25 mg were given for the first 6 months and 37.5 mg for the last 6 months. For both agents the intervals between treatments lengthened significantly over the course of the trial. Fluphenazine decanoate showed a non-significant trend for a longer duration of action coupled with a significantly lower incidence of extrapyramidal side effects.

 

点击下载:  PDF (630KB)



返 回